Skip to main content

Table 1 Baseline characteristics of 300 patients with chronic hepatitis B, Addis Ababa, Ethiopia

From: Early experiences from one of the first treatment programs for chronic hepatitis B in sub-Saharan Africa

Characteristics Number (%)
Sex
 Male 162 (54.0)
 Female 138 (46.0)
Age group (years)
 18–25 65 (21.7)
 26–35 129 (43.0)
 36–45 60 (20.0)
  > 45 46 (15.3)
Marital status
 Single 104 (34.7)
 Married 185 (61.7)
 Divorced/widowed 11 (3.6)
Previous antiviral treatment
 Yes 29 (9.7)
 No 271 (90.3)
Substance abuse
 Alcohol 5 (1.7)
 Khat 18 (6.0)
Fasting TE value (kPa) (n = 268)
  ≤ 7.9 189 (70.5)
 8.0–9.9 29 (10.8)
  > 9.9 50 (18.7)
ALT (U/L) (n = 295)
  ≤ 40 245 (83.1)
 41–80 34 (11.5)
  > 80 16 (5.4)
HBeAg (n = 289)
 Positive 27 (9.3)
 Negative 262 (90.7)
HBV viral load (IU/ml) (n = 294)
  < 2000 169 (57.5)
 2000–20,000 60 (20.4)
  ≥ 20,000 65 (22.1)
HBV genotype (n = 79)
 A 67 (84.8)
 D 12 (15.2)
Co-infections
 HIV 5 (1.7)
 HCV 4 (1.3)
 HDV (n = 294) 11 (3.7)
  1. TE transient elastography, ALT alanine aminotransferase, HBeAg hepatitis B e-antigen, HBV hepatitis B virus, HIV human immunodeficiency virus, HCV hepatitis C virus, HDV hepatitis D virus